Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
Skip to main content
Donate

Let's beat cancer sooner

New ovarian cancer blood test is promising – but screening still a way off

Category: Science blog May 5, 2015

We look at headlines about a new blood test for ovarian cancer, and why a possible routine screening test for the disease is still some way off.

Read More

Pint of Science 2015: from cows to cancer clinical trials

Category: Science blog May 1, 2015

Fancy hearing about the latest developments in cancer research? Well some of our scientists might be gathering in a venue near you to tell all.

Read More

Our milestones: the discovery of the NRAS signalling gene

Category: Science blog April 29, 2015

This entry is part 22 of 22 in the series Our milestones

We go back to the 1980s, and the crucial discovery of a fundamental cancer gene by our researchers at The Institute of Cancer Research

Read More

Advice on being active should be routine in bowel cancer care

Category: Science blog April 29, 2015

Dr Abi Fisher from our UCL Health Behaviour Research Centre blogs about her recent paper looking at physical activity rates in people with bowel cancer

Read More

TRAIL and error – flipping cancer’s self-destruct switch

Category: Science blog April 16, 2015

We explore new research showing how particular genetic faults inside cancer cells can subvert a self-destruct switch and instead encourage cancer to spread.

Read More

From snapshot to family tree – writing the evolutionary rule book of cancer

Category: Science blog April 15, 2015

Our scientists are piecing together cancer’s family tree, uncovering clues that could help develop better treatments in the future.

Read More

Science Snaps: exposing melanoma’s ‘safe haven’ to help tackle drug resistance

Category: Science blog April 13, 2015

This entry is part 11 of 11 in the series Science Snaps

We explore new research showing how healthy cells surrounding a melanoma may help the cancer cells become resistant to targeted cancer drugs.

Read More